Neurochemistry internationalAnimalsAlzheimer DiseaseAmyloid beta-PeptidesAdministrationOral
Oral administration of arginine suppresses Aβ pathology in animal models of Alzheimer's disease.
Kanako Fujii, Toshihide Takeuchi, Yuzo Fujino, Noriko Tanaka, Nao Fujino, Akiko Takeda, Eiko N Minakawa, Yoshitaka Nagai
Published: 202510.1016/j.neuint.2025.106082
Abstract
Although amyloid β (Aβ)-targeting antibody therapies for Alzheimer's disease (AD) have recently been developed, their clinical efficacy remains limited, and issues such as high cost and adverse effects have been raised. Therefore, there is an urgent…
Preview only. Read the full abstract at the source